MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6504-973-978$20.00
Mol Pharmacol 65:973-978, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nomura, T.
Right arrow Articles by Schuster, V. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nomura, T.
Right arrow Articles by Schuster, V. L.

The Two-Step Model of Prostaglandin Signal Termination: In Vitro Reconstitution with the Prostaglandin Transporter and Prostaglandin 15 Dehydrogenase

Teruhisa Nomura, Run Lu, Michael L. Pucci, and Victor L. Schuster

Departments of Medicine (V.L.S.) and Physiology & Biophysics (T.N., R.L., M.L.P., V.L.S.), Albert Einstein College of Medicine, Bronx, New York

Termination of prostaglandin (PG) signaling has been proposed to involve carrier-mediated uptake across the plasma membrane followed by cytoplasmic oxidation. Here, we tested this hypothesis directly by coexpressing the PG uptake carrier prostaglandin transporter (PGT) in various cell types with and without human PG 15 dehydrogenase (PG15DH). In HeLa cells, which express neither PGT nor PG15DH, exogenously added PGE2 or PGF2{alpha} were rapidly oxidized to the 13, 14-dihydro, 15-keto metabolites only when PGT and PG15DH were coexpressed, directly confirming the two-step hypothesis. Cells expressing PG15DH that were broken open formed more PG metabolites than cells in which the PGs could gain access to PG15DH only via PGT. Similar results were obtained using the human prostate cancer cell line LNCaP, in which endogenous PG15DH is induced after exposure to dihydrotestosterone. Because PGT in vivo is expressed in renal collecting duct epithelia, we also expressed PGT in Madin-Darby canine kidney cells grown on filters, where it mediated both the active uptake of PGE2 across the apical membrane and the transepithelial transport of PGE2 to the basolateral compartment. When PG15DH was coexpressed with PGT in these epithelial monolayers, about half of the PGE2 taken up apically was oxidized to 13, 14-dihydro, 15-keto-PGE2, which in turn exited the cells nondirectionally into both the apical and basolateral compartments. Our data represent reconstitution of the longstanding model of PG metabolism consisting of sequential carrier-mediated PG uptake, cytoplasmic oxidation, and diffusional efflux of the PG metabolite.


Received June 27, 2003; accepted December 15, 2003

Address correspondence to: V. L. Schuster, M.D., Albert Einstein College of Medicine, Belfer 1008, 1300 Morris Park Avenue, Bronx, NY 10461. E-mail: schuster{at}aecom.yu.edu




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
V. R. Holla, M. G. Backlund, P. Yang, R. A. Newman, and R. N. DuBois
Regulation of Prostaglandin Transporters in Colorectal Neoplasia
Cancer Prevention Research, July 1, 2008; 1(2): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
S. D. Markowitz
Colorectal Neoplasia Goes with the Flow: Prostaglandin Transport and Termination
Cancer Prevention Research, July 1, 2008; 1(2): 77 - 79.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
B. Yao, J. Xu, R. C. Harris, and M.-Z. Zhang
Renal localization and regulation of 15-hydroxyprostaglandin dehydrogenase
Am J Physiol Renal Physiol, February 1, 2008; 294(2): F433 - F439.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Chi, S. M. Khersonsky, Y.-T. Chang, and V. L. Schuster
Identification of a New Class of Prostaglandin Transporter Inhibitors and Characterization of Their Biological Effects on Prostaglandin E2 Transport
J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1346 - 1350.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. J. Henry, A. D'Aprile, G. Self, T. Hong, and T. S. Mann
Inhibitors of Prostaglandin Transport and Metabolism Augment Protease-Activated Receptor-2-Mediated Increases in Prostaglandin E2 Levels and Smooth Muscle Relaxation in Mouse Isolated Trachea
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 995 - 1001.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nomura, H. Y. Chang, R. Lu, J. Hankin, R. C. Murphy, and V. L. Schuster
Prostaglandin Signaling in the Renal Collecting Duct: RELEASE, REUPTAKE, AND OXIDATION IN THE SAME CELL
J. Biol. Chem., August 5, 2005; 280(31): 28424 - 28429.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S.K. Banu, J.A. Arosh, P. Chapdelaine, and M.A. Fortier
Expression of Prostaglandin Transporter in the Bovine Uterus and Fetal Membranes During Pregnancy
Biol Reprod, August 1, 2005; 73(2): 230 - 236.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Shiraki, N. Kamiya, S. Shiki, T. S. Kodama, A. Kakizuka, and H. Jingami
{alpha},{beta}-Unsaturated Ketone Is a Core Moiety of Natural Ligands for Covalent Binding to Peroxisome Proliferator-activated Receptor {gamma}
J. Biol. Chem., April 8, 2005; 280(14): 14145 - 14153.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Kang, P. Chapdelaine, J. Parent, E. Madore, P. Y. Laberge, and M. A. Fortier
Expression of Human Prostaglandin Transporter in the Human Endometrium across the Menstrual Cycle
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2308 - 2313.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics